|
|
Volumn 2, Issue 4, 2011, Pages 241-242
|
|
Adenosine monophosphate kinase activator α-lipoic acid: A promising therapeutic agent for metabolic syndrome?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE PHOSPHATE;
ADENOSINE TRIPHOSPHATE;
HEMOGLOBIN A1C;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;
METFORMIN;
PHOSPHOPROTEIN PHOSPHATASE;
THIOCTIC ACID;
THREONINE;
ANTIOXIDANT ACTIVITY;
BIOAVAILABILITY;
CARDIOVASCULAR DISEASE;
CATALYSIS;
CELL ENERGY;
CHOLESTEROL SYNTHESIS;
COMORBIDITY;
DIABETES MELLITUS;
DYSLIPIDEMIA;
EDITORIAL;
ELEVATED BLOOD PRESSURE;
ENZYME ACTIVATION;
ENZYME PHOSPHORYLATION;
EXERCISE;
FATTY ACID SYNTHESIS;
GENE EXPRESSION;
GLUCONEOGENESIS;
GLUCOSE TRANSPORT;
HUMAN;
HYPOGONADISM;
IN VIVO STUDY;
INCIDENCE;
INSULIN RESISTANCE;
LIFE EXPECTANCY;
LIFESTYLE MODIFICATION;
METABOLIC SYNDROME X;
NEUROPATHY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONALCOHOLIC FATTY LIVER;
OBESITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK FACTOR;
SLEEP DISORDERED BREATHING;
SOLUBILITY;
UROGENITAL TRACT DISEASE;
|
|
EID: 84878377474
PISSN: 20401116
EISSN: 20401124
Source Type: Journal
DOI: 10.1111/j.2040-1124.2011.00144.x Document Type: Editorial |
|
Times cited : (2)
|
|
References (6)
|
